These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 24906763)
1. Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation. Yao Y; Xie Y; Hong C; Li G; Shen H; Ji G Carbohydr Polym; 2014 Sep; 110():329-37. PubMed ID: 24906763 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
3. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects. Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132 [TBL] [Abstract][Full Text] [Related]
4. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157 [TBL] [Abstract][Full Text] [Related]
5. Characterization and antioxidant activity of the complexes of tertiary butylhydroquinone with β-cyclodextrin and its derivatives. Pu H; Sun Q; Tang P; Zhao L; Li Q; Liu Y; Li H Food Chem; 2018 Sep; 260():183-192. PubMed ID: 29699660 [TBL] [Abstract][Full Text] [Related]
6. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244 [TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of Microemulsions of Myricetin for Improving Its Antiproliferative and Antioxidative Activities and Oral Bioavailability. Guo RX; Fu X; Chen J; Zhou L; Chen G J Agric Food Chem; 2016 Aug; 64(32):6286-94. PubMed ID: 27455843 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin. Liu M; Cao W; Sun Y; He Z Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768 [TBL] [Abstract][Full Text] [Related]
9. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis- Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574 [TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation. Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954 [TBL] [Abstract][Full Text] [Related]
11. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin. Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of the inclusion complex of Baicalin (BG) with beta-CD and HP-beta-CD in solution: an antioxidant ability study. Li J; Zhang M; Chao J; Shuang S Spectrochim Acta A Mol Biomol Spectrosc; 2009 Aug; 73(4):752-6. PubMed ID: 19423384 [TBL] [Abstract][Full Text] [Related]
13. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation. Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of 16-dehydropregnenolone hydroxypropyl-β-cyclodextrin inclusion complex following peroral administration. Sun Y; Jia L; Zhou H; Mao M; Wang X; Wei L; Sun L Pharm Dev Technol; 2017 Mar; 22(2):218-228. PubMed ID: 27269370 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Liu J; Qiu L; Gao J; Jin Y Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034 [TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
17. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol. Celebioglu A; Yildiz ZI; Uyar T Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928 [TBL] [Abstract][Full Text] [Related]
18. Core-shell nanofibers of curcumin/cyclodextrin inclusion complex and polylactic acid: Enhanced water solubility and slow release of curcumin. Aytac Z; Uyar T Int J Pharm; 2017 Feb; 518(1-2):177-184. PubMed ID: 28057465 [TBL] [Abstract][Full Text] [Related]
19. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin. Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288 [TBL] [Abstract][Full Text] [Related]
20. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation. Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]